购房者入住后，发现雨季房屋漏水，并陷入"报修-维修-再漏水"的循环，购房者该如何维权？近期，北 京市平谷区人民法院审结一起相关案件，厘清了商品房渗漏时，开发商、物业公司与业主各自应承担的 法律责任，判决开发商赔偿维修费用并承担维修责任。 房屋漏水屡修不好，开发商被判担责 2015年，王先生与某置业公司签订《商品房预售合同》，购买一处商品房。 对于本案涉及的几个核心问题，法官进行了进一步的解析。 首先是关于房屋保修期如何计算。本案的核心争议点在于"保修期是否届满"。合同约定，屋面防渗漏的 保修期5年，从房屋"交付之日"起算。王先生的房屋于2017年6月交付，从表面上看，5年保修期至2022 年6月。然而，法院并未机械地以起诉时间来判断，而是审查了"质量问题是否在保修期内发生并提 出"。 王先生提供的自2020年至2022年的报修单表明，渗漏问题在保修期内已经出现，并且王先生已履行了通 知义务，因开发商的原因未及时修复完成，即便过了保修期，开发商仍应承担维修责任。反之，如果业 主在保修期内未发现或发现后未及时报修，待保修期过后再主张权利，则将面临极大的败诉风险。 其次，开发商维修了，但问题没解决，责任算尽到了吗？ ...

新京报讯（记者吴梦真）社交平台走红的原创人物形象遭服饰公司"盗用"，设计师王某维权胜诉。新京 报记者获悉，近日，北京丰台法院审理查明，某服饰公司生产销售的涉案T恤图案与王某享有著作权的 作品实质性相似，且无法证明商品合法来源，最终判决该公司承担停止侵权、赔偿损失的法律责任。 新京报记者了解到，本案中，王某是一名独立设计师，于2021年创作完成"HXXX人物形象"美术作品， 并向国家版权局提交版权登记。王某通过社交平台及自媒体账号，发布该人物形象系列作品，并持续更 新。 因此，法院认定某服饰公司侵害了王某对涉案美术作品享有的复制权和发行权，判决某服饰公司立即停 止侵权行为，并结合涉案美术作品的性质、独创性程度、某服饰公司的过错程度、涉案侵权商品的销售 价格、销售规模、涉案商品的知识产权贡献率等因素，对经济损失数额予以酌定。 法官提示，服饰生产企业在使用他人美术作品时，应当尊重他人的智力劳动成果，避免未经许可使用他 人作品。建议企业在日常经营中，建立知识产权审查机制，避免因疏忽而构成侵权。 某服饰公司在自己开设的品牌专卖店中，未经王某许可，生产、销售印有王某享有著作权的"HXXX人 物形象"美术作品的T恤衫。王某 ...

记者从尕海则岔管护中心获悉，系第三方团队工作人员在进行秋季鼠害防治工作，主要捕捉中华鼢鼠， 非盗猎。 新京报记者 苗玉薪 制作 张笑然 11月6日，网民反映甘肃尕海则岔自然保护区内，近日疑似有盗猎者非法捕捉野生动物。 ...

Core Points - Dingdong Maicai participated in the 8th China International Import Expo, sending over 100 buyers and establishing multiple cooperation intentions to introduce high-quality overseas food products to its platform [2] - The company has set up an Australia project team to enhance its import supply chain, focusing on direct procurement of quality overseas products [2] - A direct procurement agreement was signed with Australian dairy brand Bulla, committing to purchase at least 5 million yuan worth of dairy products next year [2] - Dingdong Maicai signed a procurement order exceeding 100 million yuan for New Zealand beef, increasing the scale of importing natural grass-fed beef [2] - The company plans to double its frozen durian procurement in the coming year and increase the import of niche Southeast Asian fruits [2] - Dingdong Maicai is initiating customized cooperation with quality factories, aiming to raise the customization rate of Australian products, including dairy, beverages, snacks, meat, and seafood, to over 20% in the next year [3]

Core Viewpoint - The actual controller of Wohua Pharmaceutical has changed due to a prolonged divorce property dispute, resulting in a lack of a single controlling party over the company [1][4]. Group 1: Control Change - The change in actual control stems from a divorce property dispute lasting 15 years between Zhao Bingxian and Lu Juan, with the core issue being the equity of Zhongzheng Wanrong [1]. - The Beijing Third Intermediate People's Court upheld the first-instance ruling to equally divide the shares of Zhongzheng Wanrong, leading to both parties holding 50% of the shares, thus resulting in no single controller for Wohua Pharmaceutical [1][4]. Group 2: Company Operations - Despite the change in control, Zhao Bingxian continues to serve as the chairman and legal representative of Zhongzheng Wanrong and Wohua Pharmaceutical, and the company's operations remain unaffected [2]. - Wohua Pharmaceutical has a history dating back to the Qing Dynasty and operates as a comprehensive traditional Chinese medicine enterprise with key products including Wohua Xinkeshu Tablets and Bone Health Capsules [3]. Group 3: Financial Performance - Wohua Pharmaceutical has experienced declining revenue and net profit from 2020 to 2024, with revenues of 10.06 billion, 9.43 billion, 10.15 billion, 9.1 billion, and 7.64 billion respectively, reflecting changes of 16.95%, -6.3%, 7.65%, -10.38%, and -16.02% [3][5]. - The decline in revenue is attributed to a drop in sales of core products, particularly Wohua Xinkeshu Tablets, which saw a price reduction of approximately 39% after entering a centralized procurement range [5]. - In 2025, Wohua Pharmaceutical's performance began to recover, with a reported revenue of 4.25 billion in the first half, a year-on-year increase of 7.64%, and a net profit of 446.76 million, up 303.16% [6]. Group 4: Sales Expenses - Sales expenses have consistently remained high, with figures of 4.71 billion, 4.22 billion, 5.21 billion, 4.92 billion, and 3.89 billion from 2020 to 2024, representing 46.82%, 44.75%, 51.34%, 54.07%, and 50.92% of revenue respectively [7]. - Even with a recovery in 2025, sales expenses reached 2.15 billion, accounting for 50.59% of revenue, indicating that over half of the revenue is allocated to sales efforts [7].

Core Insights - Luckin Coffee is actively participating in the global coffee trade by entering multiple national pavilions at the 8th China International Import Expo, showcasing its innovative vitality in the coffee industry [2] - The global coffee consumption is on the rise, particularly in emerging markets like China, presenting new development opportunities for the industry [2] - Luckin Coffee has significantly expanded its supply chain and upstream sourcing, establishing a direct procurement and industry collaboration system across multiple countries [2] Company Developments - In November 2024, Luckin Coffee signed a five-year memorandum to purchase 240,000 tons of coffee beans from Brazil, valued at 10 billion yuan, making it the largest buyer of Brazilian coffee beans in China [2] - In 2024, Luckin Coffee's procurement accounted for approximately 60% of Brazil's coffee bean exports to China [2] - Luckin Coffee plans to establish a "Luckin Coffee Exclusive Fresh Coconut Island" in Indonesia, aiming to procure 1 million tons of high-standard fresh coconuts over the next five years [2] Local Initiatives - In 2024, Luckin Coffee will establish its first coffee fresh fruit processing plant in Yunnan, China, providing training for local coffee farmers to promote sustainable development in the domestic coffee industry [3] - The procurement volume of coffee beans from Yunnan has been rapidly increasing, especially after 2023, with significant growth in the purchase of espresso blend coffee beans and fresh coffee fruits [3] Strategic Vision - At the Import Expo, Luckin Coffee's Public Relations Manager emphasized the company's vision of deepening connections with global core production areas, leveraging a large consumer market to drive multilateral trade cooperation [3] - The theme of the Import Expo, "New Era, Shared Future," aligns with Luckin Coffee's commitment to sharing development opportunities with upstream producers [3]

素有"减肥神药"之称的司美格鲁肽自上市后就热度不减。本土企业信达生物近日宣布，其自主研发的 GCG/GLP-1双受体激动剂玛仕度肽（mazdutide）在与司美格鲁肽的头对头临床试验中，在血糖控制和 体重管理的综合疗效上显著优于后者，该试验主要针对国内2型糖尿病（T2D）合并肥胖患者。有研报 指出，到2030年，全球肥胖与代谢类药物市场规模有望突破一千亿美元，其中GLP-1药物将是核心驱动 力之一。另一边，虽手握一年销售额近300亿美元的司美格鲁肽，诺和诺德也已经考虑到激烈的竞争而 开启转型计划。减重药物市场的"热闹"一直不断。 国产药物玛仕度肽"头对头"战胜司美格鲁肽 据信达生物披露，在Ⅲ期临床试验（DREAMS-3）中，其自主研发的GCG/GLP-1双受体激动剂玛仕度 肽（mazdutide）达成主要终点。结果显示，在中国2型糖尿病（T2D）合并肥胖患者中，玛仕度肽在血 糖控制和体重管理的综合疗效上显著优于知名产品司美格鲁肽，并在空腹血糖、腰围、收缩压及甘油三 酯等多项心血管代谢风险因素上展现改善。 值得注意的是，DREAMS-3是全球首个在糖尿病治疗领域，将国产GCG/GLP-1双受体激动剂玛仕度肽 与 ...

Core Insights - The rapid growth of the internet lending market in China has reached nearly 10 trillion yuan by June 2025, becoming a crucial financing channel for small and micro enterprises, individual businesses, and urban and rural residents [1] - The implementation of the new regulations aims to transition the internet lending industry from "wild growth" to "compliance-driven" practices, addressing issues such as opaque fees, exorbitant interest rates, and imbalanced risk control responsibilities [1][2] - Recent reports indicate a resurgence of predatory lending practices, including high annualized rates exceeding 2000%, which could exacerbate financial risks for consumers and disrupt the normal operations of financial institutions [1][2] Regulatory Framework - The new regulations require commercial banks to enhance centralized management responsibilities and strictly control comprehensive financing costs [1] - A governance system is proposed that emphasizes regulatory transparency, institutional self-discipline, technological intelligence, and efficient judicial processes to systematically prevent the recurrence of lending irregularities [2] Technological Solutions - The establishment of a "full-process intelligent risk control + regulatory technology empowerment + consumer protection digitalization" system is recommended to accurately identify and intercept illegal lending activities in real-time [2] - Preemptive measures include using OCR and AI technologies to verify the compliance of lending institutions and prevent misleading advertising practices [2] - Real-time monitoring of loan contracts and payment pages is suggested to detect and alert users about hidden fees and other irregular charges [2][3] Accountability and Oversight - Financial institutions are urged to rigorously assess lending agencies and ensure compliance with the new regulations, focusing on their financial health and risk management capabilities [4] - A digital regulatory platform is proposed to enhance the effectiveness of financial oversight, utilizing advanced technologies to monitor risks in the lending sector [4] Collaborative Efforts - A multi-faceted approach involving regulatory bodies, financial institutions, technology companies, consumers, and media is essential to combat illegal lending practices effectively [5] - Emphasis is placed on coordinated efforts across various governmental departments to address issues such as excessive intermediary fees and predatory lending behaviors [5] - The goal is to balance strict compliance with inclusive practices, ensuring that financial services return to their core purpose of supporting the real economy and consumers [5]

Core Viewpoint - The company BaWang has faced multiple product quality issues, including recent non-compliance in a special inspection by the Guangzhou Market Supervision Administration, raising concerns about its product safety and regulatory adherence [1][2]. Group 1: Recent Inspection Results - BaWang's products were part of a special inspection involving 2066 batches of cosmetics, with 40 batches failing to meet regulations, including BaWang's "Black Sesame Softening Shampoo" due to excessive levels of preservatives [1]. - The specific non-compliance was related to the mixture of Methylchloroisothiazolinone and Methylisothiazolinone, which exceeded the allowed limit of 0.0015% [1]. Group 2: Historical Compliance Issues - This is not the first instance of BaWang facing product non-compliance; in 2022, the "Zunyan Clean Fragrance Shampoo" was penalized for not meeting the required active ingredient ratio, resulting in fines totaling 96,000 yuan [2]. - In 2010, BaWang was penalized for misleading advertising regarding its hair growth products, violating cosmetic regulations [2]. Group 3: Financial Performance - BaWang reported a net profit of 13.63 million yuan in 2023, but this figure is expected to drop by over 51% to approximately 6.6 million yuan in 2024 [3]. - For the first half of 2025, BaWang's revenue increased by 9.3% to 120.1 million yuan, yet the net profit plummeted by 328.93% to a loss of 2.77 million yuan, indicating ongoing challenges in profitability despite revenue growth [3].

纪录片《书缘：纽约公共图书馆》（2017）画面。 据lit hub等媒体报道，美国最大的图书分销商之一贝克泰勒公司（Baker & Taylor）宣布即将关闭，计划 在2025年底前停止所有业务活动。这将导致美国的图书分销渠道（至少在短期内）陷入混乱，预计影响 范围达到全美约6000家图书馆。 贝克泰勒公司成立于1828年，曾是美国图书馆印刷和视听资料的最大分销商之一，服务超过4000家机构 客户，拥有900多名员工。除了分销资料外，该公司还提供定制化的图书馆服务，包括可直接上架的资 料等面向图书馆和出版商的各类产品和服务。业务方面，从2019 年开始，该公司停止向书店供货，转 而专注于图书馆和教育机构。 这场危机要归咎于私募股权投资。过去十年间，一系列的收购和剥离削弱了这家公司的基础设施，令高 层管理人员长期处于焦虑不安的状态。管理不善还伴随着一连串的"运气不佳"。今年早春，就在债权人 催收该公司贷款之际，一家竞争对手对其提起了诉讼。今年夏天早些时候，该公司的服务器也遭受了一 次严重的网络攻击。 据《出版人周刊》报道，该公司首席执行官兼所有者阿曼·科查尔近日在一次员工会议上告诉员工们， 由于没有买家，并且主 ...